Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Efficacy of Bupropion, Sertraline, and Venlafaxine in Bipolar Depression
NCT00001483Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jun 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) comparing Bupropion, Sertraline and Venlafaxine (3 arms). Primary endpoints: Inventory for Depressive Symptoms - Clinician form at 1 year, Clinical Global Impression scale for Bipolar Disorder at 1 year and 1 more. Started Jun 1995; status: completed.
02
Drugs
bupropionsertralinevenlafaxine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00001483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001483.